Michael Kullmann

1.6k total citations
14 papers, 1.3k citations indexed

About

Michael Kullmann is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Michael Kullmann has authored 14 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 9 papers in Oncology and 4 papers in Cancer Research. Recurrent topics in Michael Kullmann's work include Cancer-related Molecular Pathways (9 papers), Ubiquitin and proteasome pathways (4 papers) and Estrogen and related hormone effects (3 papers). Michael Kullmann is often cited by papers focused on Cancer-related Molecular Pathways (9 papers), Ubiquitin and proteasome pathways (4 papers) and Estrogen and related hormone effects (3 papers). Michael Kullmann collaborates with scholars based in Austria, Germany and United States. Michael Kullmann's co-authors include Ludger Hengst, Andrew C.B. Cato, Ulrich Göpfert, Basile Siewe, Peter Herrlich, Susanne Heck, Andreas Gast, Hans J. Rahmsdorf, Helmut Ponta and Heidelinde Jäkel and has published in prestigious journals such as Cell, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Michael Kullmann

13 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Kullmann Austria 11 857 411 346 211 195 14 1.3k
Daniel Khodabakhsh United States 5 543 0.6× 277 0.7× 225 0.7× 142 0.7× 195 1.0× 6 888
Guillermo P. Vicent Spain 25 1.5k 1.8× 325 0.8× 547 1.6× 211 1.0× 270 1.4× 53 2.0k
Larbi Amazit France 25 1.2k 1.4× 349 0.8× 595 1.7× 217 1.0× 128 0.7× 40 2.0k
Akhilesh K. Nagaich United States 15 973 1.1× 374 0.9× 298 0.9× 167 0.8× 149 0.8× 19 1.3k
Udo Stropp Germany 9 581 0.7× 294 0.7× 912 2.6× 188 0.9× 413 2.1× 11 1.5k
J. Don Chen United States 15 1.4k 1.6× 245 0.6× 801 2.3× 109 0.5× 199 1.0× 17 1.9k
Stephan P. Tenbaum Spain 17 1.2k 1.4× 339 0.8× 281 0.8× 223 1.1× 109 0.6× 23 1.6k
Wei‐Hsiung Yang United States 19 694 0.8× 237 0.6× 260 0.8× 348 1.6× 198 1.0× 39 1.3k
Hetti Poukka Finland 13 1.1k 1.3× 251 0.6× 629 1.8× 150 0.7× 132 0.7× 15 1.5k
L. S. P. Davidson United Kingdom 24 1.1k 1.3× 169 0.4× 180 0.5× 115 0.5× 155 0.8× 50 1.6k

Countries citing papers authored by Michael Kullmann

Since Specialization
Citations

This map shows the geographic impact of Michael Kullmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Kullmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Kullmann more than expected).

Fields of papers citing papers by Michael Kullmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Kullmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Kullmann. The network helps show where Michael Kullmann may publish in the future.

Co-authorship network of co-authors of Michael Kullmann

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Kullmann. A scholar is included among the top collaborators of Michael Kullmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Kullmann. Michael Kullmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Jäkel, Heidelinde, et al.. (2022). Inability to phosphorylate Y88 of p27Kip1 enforces reduced p27 protein levels and accelerates leukemia progression. Leukemia. 36(7). 1916–1925. 2 indexed citations
2.
Kullmann, Michael, et al.. (2021). Stimulation of c-Jun/AP-1-Activity by the Cell Cycle Inhibitor p57Kip2. Frontiers in Cell and Developmental Biology. 9. 664609–664609. 14 indexed citations
3.
Kullmann, Michael, et al.. (2020). The CDK inhibitor p57Kip2 enhances the activity of the transcriptional coactivator FHL2. Scientific Reports. 10(1). 7140–7140. 6 indexed citations
4.
Kullmann, Michael, et al.. (2018). Cold-inducible RNA-binding protein (CIRP) induces translation of the cell-cycle inhibitor p27Kip1. Nucleic Acids Research. 46(6). 3198–3210. 28 indexed citations
5.
Jäkel, Heidelinde, Michael Kullmann, Bénédicte Sohm, et al.. (2016). Caspases uncouple p27Kip1 from cell cycle regulated degradation and abolish its ability to stimulate cell migration and invasion. Oncogene. 35(35). 4580–4590. 22 indexed citations
6.
Kullmann, Michael, et al.. (2014). Statin-induced depletion of geranylgeranyl pyrophosphate inhibits cell proliferation by a novel pathway of Skp2 degradation. Oncotarget. 6(5). 2889–2902. 20 indexed citations
7.
Kullmann, Michael, Heidelinde Jäkel, Alexander Trockenbacher, et al.. (2013). The p27–Skp2 axis mediates glucocorticoid-induced cell cycle arrest in T-lymphoma cells. Cell Cycle. 12(16). 2625–2635. 28 indexed citations
8.
Grimmler, Matthias, Yuefeng Wang, Thomas Mund, et al.. (2007). Cdk-Inhibitory Activity and Stability of p27 Are Directly Regulated by Oncogenic Tyrosine Kinases. Cell. 128(2). 269–280. 272 indexed citations
9.
Halfter, Hartmut, Matthias Friedrich, Michael Kullmann, et al.. (2006). Oncostatin M Induces Growth Arrest by Inhibition of Skp2, Cks1, and Cyclin A Expression and Induced p21 Expression. Cancer Research. 66(13). 6530–6539. 29 indexed citations
10.
Kullmann, Michael, Ulrich Göpfert, Basile Siewe, & Ludger Hengst. (2002). ELAV/Hu proteins inhibit p27 translation via an IRES element in the p27 5′UTR. Genes & Development. 16(23). 3087–3099. 290 indexed citations
11.
Kullmann, Michael, Jean Schneikert, Jürgen Moll, et al.. (1998). RAP46 Is a Negative Regulator of Glucocorticoid Receptor Action and Hormone-induced Apoptosis. Journal of Biological Chemistry. 273(23). 14620–14625. 122 indexed citations
12.
Göttlicher, Martin, Stefanie Heck, Vassilis Doucas, et al.. (1996). Interaction of the Ubc9 human homologue with c-Jun and with the glucocorticoid receptor. Steroids. 61(4). 257–262. 67 indexed citations
13.
Heck, Susanne, Michael Kullmann, Andreas Gast, et al.. (1994). A distinct modulating domain in glucocorticoid receptor monomers in the repression of activity of the transcription factor AP-1.. The EMBO Journal. 13(17). 4087–4095. 442 indexed citations
14.
Kullmann, Michael. (1960). Is Idealism Really Nonsense?. Philosophy and Phenomenological Research. 20(4). 535–535. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Daniel Khodabakhsh Breakdown of academic impact, for papers by Guillermo P. Vicent Breakdown of academic impact, for papers by Larbi Amazit Breakdown of academic impact, for papers by Akhilesh K. Nagaich Breakdown of academic impact, for papers by Udo Stropp Breakdown of academic impact, for papers by J. Don Chen Breakdown of academic impact, for papers by Stephan P. Tenbaum Breakdown of academic impact, for papers by Wei‐Hsiung Yang Breakdown of academic impact, for papers by Hetti Poukka Breakdown of academic impact, for papers by L. S. P. Davidson
Rankless by CCL
2026